Guangbo Fu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Effects and risks of endocrine disrupting chemicals
- Toxic Organic Pollutants Impact
Papers in
-
- Epigenetics and DNA Methylation 5
- DNA Repair Mechanisms 4
- Circular RNAs in diseases 4
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 6
- Cancer, Lipids, and Metabolism 4
- Co-authors
- Meilin Wang (15 shared papers)Zhengdong Zhang (11 shared papers)Xinru Wang (10 shared papers)Yankai Xia (8 shared papers)Pengfei Zhu (5 shared papers)Chuncheng Lu (5 shared papers)Changjun Yin (7 shared papers)Xiaobing Niu (8 shared papers)
- Journals
- Mutation research. Fundamental and molecular mechanisms of mutagenesis (2 papers)Oncotarget (2 papers)Carcinogenesis (2 papers)International Journal of Cancer (2 papers)Diagnostic Pathology (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Guangbo Fu
41 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 383
- Health, Toxicology and Mutagenesis 205
- Reproductive Medicine 102
- Molecular Biology 563
- Drug Discovery 1
Countries citing papers authored by Guangbo Fu
This map shows the geographic impact of Guangbo Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangbo Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangbo Fu more than expected).
Fields of papers citing papers by Guangbo Fu
This network shows the impact of papers produced by Guangbo Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangbo Fu. The network helps show where Guangbo Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Guangbo Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 130 | |
| 2 | 2015 | 77 | |
| 3 | 2012 | 73 | |
| 4 | 2009 | 58 | |
| 5 | 2010 | 56 | |
| 6 | 2013 | 56 | |
| 7 | 2016 | 55 | |
| 8 | 2013 | 44 | |
| 9 | 2008 | 41 | |
| 10 | 2009 | 40 | |
| 11 | 2020 | 39 | |
| 12 | 2018 | 35 | |
| 13 | 2009 | 33 | |
| 14 | 2007 | 30 | |
| 15 | 2020 | 30 | |
| 16 | 2020 | 30 | |
| 17 | 2008 | 29 | |
| 18 | 2015 | 25 | |
| 19 | 2020 | 24 | |
| 20 | 2017 | 24 |
About Guangbo Fu
Guangbo Fu is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 43 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Bladder and Urothelial Cancer Treatments (6 papers), MicroRNA in disease regulation (6 papers), Epigenetics and DNA Methylation (5 papers), DNA Repair Mechanisms (4 papers), Sperm and Testicular Function (4 papers), Cancer, Lipids, and Metabolism (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (383 citations), Health, Toxicology and Mutagenesis (205 citations), Reproductive Medicine (102 citations), Molecular Biology (563 citations) and Drug Discovery (1 citation). Guangbo Fu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Meilin Wang, Zhengdong Zhang, Xinru Wang, Yankai Xia, Pengfei Zhu, Chuncheng Lu, Changjun Yin, Xiaobing Niu, Na Tong and Minjian Chen. Their work appears in journals such as Mutation research. Fundamental and molecular mechanisms of mutagenesis, Oncotarget, Carcinogenesis, International Journal of Cancer and Diagnostic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.